Compare CDLX & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDLX | NMTC |
|---|---|---|
| Founded | 2008 | 2009 |
| Country | United States | United States |
| Employees | 224 | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.2M | 29.2M |
| IPO Year | 2018 | 2010 |
| Metric | CDLX | NMTC |
|---|---|---|
| Price | $5.16 | $3.20 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $2.25 | ★ $11.90 |
| AVG Volume (30 Days) | ★ 324.6K | 25.8K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 50.13 | ★ 80.43 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $233,273,000.00 | $9,097,692.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.82 | $31.90 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 163.47 |
| 52 Week Low | $0.55 | $0.55 |
| 52 Week High | $6.40 | $5.40 |
| Indicator | CDLX | NMTC |
|---|---|---|
| Relative Strength Index (RSI) | 81.03 | 40.60 |
| Support Level | $0.83 | $0.69 |
| Resistance Level | $6.40 | $4.87 |
| Average True Range (ATR) | 0.41 | 0.21 |
| MACD | 0.30 | -0.04 |
| Stochastic Oscillator | 79.49 | 27.69 |
Cardlytics Inc is a commerce media platform that is designed to make commerce smarter and rewarding for everyone. At the core of its commerce media platform is the financial media network that it runs within its partners' digital channels, which includes online and mobile applications (the Cardlytics platform). Additionally, it operates an identity resolution platform that utilizes point-of-sale (POS) data, including product-level purchase data, to enable marketers to perform analytics and targeted loyalty marketing and also measure the impact of their marketing (the Bridg platform). It operates in three segments: the Cardlytics platform in the U.S.; the Cardlytics platform in the U.K.; and the Bridg platform. The majority of the revenue is derived from the Cardlytics platform.
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.